Additionally, IHC staining revealed that metastatic tumors with high CDX2 expression had higher E-cadherin expression in comparison to metastatic tumors with low CDX2 expression (Figure 4F and Supplemental Figure 5G). The gene discussed is CDX2; the disease is metastatic neoplasm.